FDA Approved: KUVAN — Original Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

The FDA approved Kuvan (sapropterin dihydrochloride) from BioMarin as the original approval for treatment of phenylketonuria to lower blood phenylalanine in res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

ORIG AP for KUVAN (SAPROPTERIN DIHYDROCHLORIDE)